GlassScriptPhysician profile
Danyal Khan
NPI 1497246391
$3,373.48
in general payments reported to CMS, 2019-2025
12 companies · $1,838 in 2025
The $1,838 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $315 · 2024: $1,221 · 2025: $1,838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,059 · Education: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,058.95 |
| Education | $314.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $988.30 | 2024-2025 | Onyx Frontier, Ffrangio, Symplicity G3 |
| Boston Scientific Corporation | $502.45 | 2024-2025 | Avvigo Guidance System, Rotapro, Eluvia |
| Philips North America LLC | $469.71 | 2025 | Coronary Other, Specialty Tempus Ic Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $329.73 | 2023-2024 | Jardiance |
| Abiomed | $249.17 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $172.78 | 2023-2025 | Pascal, Sapien 3 Ultra Resilia |
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| Teleflex LLC | $130.29 | 2025 | Orsiro Mission |
| Astrazeneca Pharmaceuticals LP | $124.41 | 2024-2025 | Wainua |
| Terumo Medical Corporation | $117.31 | 2025 | Angio-Seal, Glidewire, Tr Band |
| Pfizer INC. | $96.57 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $49.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danyal Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.